Related Experiment Video
Updated: Jul 18, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Fatty acids and sleep in depressed inpatients
G Irmisch1, D Schläfke, W Gierow
1Department of Psychiatry and Psychotherapy, Rostock University, Gehlsheimer Strasse 20, D-18147 Rostock, Germany. gisela.irmisch@med.uni-rostock.de
Abstract:
Sleep disturbances belong to the most frequent symptoms of depression. Low concentrations of n-3-fatty acids might represent one determinant within that process. Therefore, the aim of the study was to examine the relationships between serum fatty acid concentrations and severity of sleep disturbances in depressives. Serum fatty acids were measured gaschromatographically in 118 depressive inpatients (51 males; 67 females; age 45.4+/-12.0 years), divided into subgroups according to three degrees of sleep disturbances (BDI-item). At admission and discharge, we found significant negative correlations between the degree of sleep disturbances and fatty acid concentrations (myristic, palmitic, palmitoleic, oleic, linoleic, eicosadienoic and docosahexaenoic acid). At both assessments palmitoleic and eicosadienoic acids had the strongest connections with sleep performance. Palmitoleic and oleic acid seem to be especially important for sleep disorders, may be due to their function as precursors of the sleep inducing oleamide. Linoleic and eicosadienoic acid could be helpful for maintaining sleep because they are precursors of the sleep mediator PGD2. In contrast to our hypothesis, there is not only a significant lack of n-3 fatty acids but also of special monoenoic and n-6 fatty acids in sleep-disturbed depressives.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Management of Insomnia
G-protein Coupled Receptors
CNS Depressants: Barbiturates and Benzodiazepines
